[Form 4] Valvoline Inc. Insider Trading Activity

Rhea-AI Filing Summary

IonQ, Inc. (Form 144) discloses a planned sale of 6,789 common shares through Morgan Stanley Smith Barney on or about 07/11/2025. The shares have an aggregate market value of $311,818.77 and represent an immaterial ~0.003% of the 247.8 million shares outstanding. The securities were acquired as restricted stock units on 07/11/2025. 

The filing also lists prior 10b5-1 program transactions for the same account holder—30,696 shares sold in the past three months for total proceeds of $1.27 million (25,696 shares on 06/11/2025 and 5,000 shares on 07/07/2025). 

Form 144 serves only as advance notice and does not guarantee the sale will occur. The share count and dollar amounts involved are small relative to IonQ’s float, suggesting limited direct market impact, yet ongoing insider selling can be monitored by investors for sentiment signals.

Insights

Securities Analyst

TL;DR insider plans to sell 6,789 shares; scale appears immaterial.

Form 144 indicates a routine sale under Rule 144 and possibly linked to an established 10b5-1 plan. The dollar value ($312k) is negligible versus IonQ’s market capitalization and float, so liquidity impact is minimal. Nevertheless, cumulative sales of ~37k shares since June may draw attention from investors tracking insider sentiment. Absent other disclosures, the event is neutral for valuation.

Risk Analyst

TL;DR small insider sale; monitor frequency rather than size.

Insider activity itself is not a red flag, particularly under a 10b5-1 plan. The filing affirms the seller is unaware of undisclosed adverse information, reducing information-asymmetry risk. Still, repeated divestitures within a short window can influence perception if they persist. Overall, the filing is not materially impactful to IonQ’s risk profile.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Flees Lori Ann

(Last) (First) (Middle)

100 VALVOLINE WAY

SUITE 100

(Street)

LEXINGTON KY 40509

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
VALVOLINE INC [ VVV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President & CEO

3. Date of Earliest Transaction (Month/Day/Year)
07/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock Units	(1)	07/10/2025		A		46(2)		(3)	(3)	Common Stock	46	$39.05	9,877	D

Explanation of Responses:

1. Each unit represents a contingent right to receive one share of Valvoline common stock upon distribution from the Valvoline Inc. 2016 Deferred Compensation Plan for Employees (the "Deferred Compensation Plan").

2. Represents the number of deferred stock units acquired by the reporting person under the Deferred Compensation Plan through salary deferral.

3. Shares of Valvoline Common Stock become payable in respect of the units upon the event of an unforeseeable emergency (as defined in the Deferred Compensation Plan) or the Reporting Person's death, disability or separation from service, in accordance with the terms of the Deferred Compensation Plan.

Remarks:

	/s/ Ian C. Lofwall, Attorney-in-Fact	07/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many IonQ (IONQ) shares are proposed for sale in this Form 144?

The notice covers 6,789 common shares.

What is the estimated value of the shares referenced in IonQ’s Form 144?

The aggregate market value is $311,818.77.

When is the anticipated sale date for the IonQ shares?

The approximate sale date listed is 07/11/2025.

How many IonQ shares were sold by the filer in the past three months?

A total of 30,696 shares were sold, generating $1.27 million in gross proceeds.

Does the planned sale materially affect IonQ’s share count?

No. The 6,789 shares represent about 0.003% of the 247.8 million shares outstanding.